With single payer, the government suddenly holds a lot of cards even without explicitly making laws. Most drugs have alternatives. Facing the threat of having all drugs that have sufficiently good alternatives disappear off the approved prescription lists makes most pharmaceutical companies quite reasonable to negotiate with even for players like the UK government that "only" represents 60 million people.